Clinical Trial Update: Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents

View source ↗

Summary

This entry reports a clinical trial evaluating novel MR contrast agents for assessing cirrhosis and malignant hepatic lesions, including hepatocellular carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis of the Liver
• Hepatocellular Carcinoma

Snippet

Sponsor: San Francisco Veterans Affairs Medical Center | Conditions: Hepatocellular Carcinoma | Status: UNKNOWN